BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 9516973)

  • 1. Genetic abnormalities in parathyroid nodules of uremic patients.
    Chudek J; Ritz E; Kovacs G
    Clin Cancer Res; 1998 Jan; 4(1):211-4. PubMed ID: 9516973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progression of uremic hyperparathyroidism involves allelic loss on chromosome 11.
    Falchetti A; Bale AE; Amorosi A; Bordi C; Cicchi P; Bandini S; Marx SJ; Brandi ML
    J Clin Endocrinol Metab; 1993 Jan; 76(1):139-44. PubMed ID: 8421078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parathyroid glands in uraemic patients with refractory hyperparathyroidism: histopathology and p53 protein expression analysis.
    Martin LN; Kayath MJ; Vieira JG; Nosé-Alberti V
    Histopathology; 1998 Jul; 33(1):46-51. PubMed ID: 9726048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rare somatic inactivation of the multiple endocrine neoplasia type 1 gene in secondary hyperparathyroidism of uremia.
    Tahara H; Imanishi Y; Yamada T; Tsujimoto Y; Tabata T; Inoue T; Inaba M; Morii H; Nishizawa Y
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4113-7. PubMed ID: 11095441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microsatellite instability and loss of heterozygosity in primary and secondary proliferative lesions of the parathyroid gland.
    Koshiishi N; Chong JM; Fukasawa T; Ikeno R; Tanaka A; Kanazawa K; Ogura M; Ebuchi M; Takizawa T; Funata N; Fukayama M
    Lab Invest; 1999 Sep; 79(9):1051-8. PubMed ID: 10496523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphatemia is related to chromosomal aberrations of parathyroid glands in patients with hyperparathyroidism.
    Chudek J; Nagy A; Kokot F; Podwinski A; Wiecek A; Ritz E; Kovacs G
    J Nephrol; 2007; 20(2):164-72. PubMed ID: 17514620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
    Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
    Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accumulation of allelic changes at chromosomes 7p, 18q, and 2 in parathyroid lesions of uremic patients.
    Nagy A; Chudek J; Kovacs G
    Lab Invest; 2001 Apr; 81(4):527-33. PubMed ID: 11304572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chromosome abnormalities in hyperparathyroidism: utility of comparative genomic hybridization in the study of parathyroid hyperplasias].
    Afonso S; Cigudosa JC; Santamaría I; Otero A; Menárguez J; García Miranda JL
    Nefrologia; 2003; 23 Suppl 2():2-6. PubMed ID: 12778845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular evidence supporting field effect in urothelial carcinogenesis.
    Jones TD; Wang M; Eble JN; MacLennan GT; Lopez-Beltran A; Zhang S; Cocco A; Cheng L
    Clin Cancer Res; 2005 Sep; 11(18):6512-9. PubMed ID: 16166427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia.
    Arnold A; Brown MF; Ureña P; Gaz RD; Sarfati E; Drüeke TB
    J Clin Invest; 1995 May; 95(5):2047-53. PubMed ID: 7738171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allelic loss on chromosome 11 is uncommon in parathyroid glands of patients with hypercalcaemic secondary hyperparathyroidism.
    Farnebo F; Farnebo LO; Nordenström J; Larsson C
    Eur J Surg; 1997 May; 163(5):331-7. PubMed ID: 9195165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal chromosomal defects in the molecular pathogenesis of refractory hyperparathyroidism of uremia.
    Imanishi Y; Tahara H; Palanisamy N; Spitalny S; Salusky IB; Goodman W; Brandi ML; Drüeke TB; Sarfati E; Ureña P; Chaganti RS; Arnold A
    J Am Soc Nephrol; 2002 Jun; 13(6):1490-8. PubMed ID: 12039978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parathyroid growth and suppression in renal failure.
    Lewin E; Huan J; Olgaard K
    Semin Dial; 2006; 19(3):238-45. PubMed ID: 16689976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonal origin of lymph node metastases in bladder carcinoma.
    Jones TD; Carr MD; Eble JN; Wang M; Lopez-Beltran A; Cheng L
    Cancer; 2005 Nov; 104(9):1901-10. PubMed ID: 16196038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The genetic background of uremic secondary hyperparathyroidism.
    Aucella F; Morrone L; Stallone C; Gesualdo L
    J Nephrol; 2005; 18(5):537-47. PubMed ID: 16299679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis in parathyroid hyperplasia of patients with primary or secondary uremic hyperparathyroidism.
    Zhang P; Duchambon P; Gogusev J; Nabarra B; Sarfati E; Bourdeau A; Drüeke TB
    Kidney Int; 2000 Feb; 57(2):437-45. PubMed ID: 10652020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Loss of heterozygosity on chromosome 9p13-23 in microdissected laryngeal squamous cell carcinoma by microsatellite analysis].
    Xu X; An Q; Zhang J; Tang P; Cheng S
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Oct; 36(5):367-71. PubMed ID: 12761947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allelic loss in parathyroid neoplasia can help characterize malignancy.
    Hunt JL; Carty SE; Yim JH; Murphy J; Barnes L
    Am J Surg Pathol; 2005 Aug; 29(8):1049-55. PubMed ID: 16006799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonal emergence in uremic parathyroid hyperplasia is not related to MEN1 gene abnormality.
    Shan L; Nakamura Y; Murakami M; Nakamura M; Naito A; Kawahara K; Utsunomiya H; Mori I; Kakudo K
    Jpn J Cancer Res; 1999 Sep; 90(9):965-9. PubMed ID: 10551325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.